Your browser doesn't support javascript.
loading
In The Line of Treatment: A Systematic Review of Paroxysmal Supraventricular Tachycardia.
Ahmad, Farrukh; Abu Sneineh, Majdi; Patel, Ravi S; Rohit Reddy, Sai; Llukmani, Adiona; Hashim, Ayat; Haddad, Dana R; Gordon, Domonick K.
Afiliación
  • Ahmad F; Emergency Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Abu Sneineh M; Emergency Medicine, Beaumont Hospital, Dublin, IRL.
  • Patel RS; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Rohit Reddy S; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Llukmani A; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Hashim A; Medical Education and Simulation, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Haddad DR; Internal Medicine/Pediatrics, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Gordon DK; Plastic and Reconstructive Surgery, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Cureus ; 13(6): e15502, 2021 Jun.
Article en En | MEDLINE | ID: mdl-34268033
Paroxysmal supraventricular tachycardia (PSVT) is a common tachyarrhythmia, and an electrocardiogram is the best tool for making a diagnosis. If Valsalva maneuvers and carotid sinus massage do not give positive results, then the next choice is either adenosine or calcium channel blockers. At this time, adenosine is the drug of choice of treatment. Verapamil and diltiazem are the most commonly used calcium channel blockers (CCBs). This review aimed to compare the efficacy of both drugs in the treatment of PSVT. We utilized the databases PubMed Central and Medline by using keywords: "calcium channel blockers OR adenosine AND supraventricular tachycardia." In the end, we finalized 32 studies, including observational studies, literature reviews, systematic reviews/metanalysis, and randomized control trials. We included articles only in the English language and related to humans. Two authors completed the quality assessment and evaluation of bias according to specific guidelines. Only high-quality studies were included in this systematic review based on the cut-off score of seven or above. Calcium channel blockers have a longer half-life than adenosine and were previously used as the drug of choice in the treatment of PSVT. Calcium channel blockers are safe if given slowly; however, adenosine is safer and useful when an electrocardiogram is uncertain. We compared both drugs in certain aspects and found equal efficacy. Though safer, adenosine was found to have a higher cost and a higher probability of re-initiation arrhythmia compared to calcium channel blockers.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Systematic_reviews Idioma: En Revista: Cureus Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Systematic_reviews Idioma: En Revista: Cureus Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos